Gloria Isabel del Pozo

Gloria Isabel del Pozo

Auto-generated profile, based on publicly available information

Gloria Isabel del Pozo

Maimonides Biomedical Research Institute of Cordoba (IMIBIC)

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2025 in European Psychiatry
Verified
Journal Article
Open access
PDF file
MJMaría Jose Jaén-Moreno
María Jose Jaén-Moreno
DLDavid Laguna-Muñoz
David Laguna-Muñoz
GPGloria Isabel del Pozo
Gloria Isabel del Pozo
CCCristina Camacho-Rodríguez
Cristina Camacho-Rodríguez
IGIpek Guler
Ipek Guler
FSFernando Sarramea
Fernando Sarramea
Background: The population with a serious mental illness (SMI) shows a high risk of premature mortality. Overexposed to multiple health risks throughout life, their main threat is physical illness, which starts earlier and is not diagnosed in time. Developing preventive actions is a public health priority. Methods: This longitudinal prospective study evaluated the predictive value of lung function on all-cause mortality in patients with schizophrenia (SCHIZ) or bipolar disorder. Patients aged 40–70 years, active smokers, and without preexisting respiratory disease underwent spirometry following American Thoracic Society/European Respiratory Society 2021 standards. Mortality data were collected through December 2022. Cox proportional hazards models and Kaplan–Meier survival curves analyzed the association between lung function, specifically forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), and mortality, adjusting for relevant confounders (age, gender, abdominal circumference, and comorbidities). Results: Of 107 participants (mean age 49.3 years, 63.3% male) with SMI (72% SCHIZ) and active smokers, 8 (7.5%) died during the 6-year follow-up (5 cardiovascular and 3 cancer). Mean z -scores were −1.41 (SD = 1.22) for FEV1 and −0.99 (SD = 1.16) for FVC. Lower FEV1 and FVC z -scores were significantly associated with increased mortality risk ( p = 0.002 and p = 0.009, respectively). Kaplan–Meier analysis confirmed this association for FEV1 ( p = 0.039) and FVC ( p = 0.007) but not for gender, comorbidities (hypertension, diabetes, and dyslipidemia), or FEV1/FVC. A multivariate Cox regression model, adjusting for age and abdominal circumference, confirmed the independent predictive value of lower FEV1 z -score for mortality (hazard regression = 0.473, 95% confidence interval: 0.220–0.979, p = 0.044). Conclusions: Poorer lung function, especially lower FEV1, was independently associated with all-cause mortality in SMI. Spirometry, an easily implementable technique, could help to detect at-risk individuals and favor prevention initiatives.